湖南师范大学学报(医学版)
湖南師範大學學報(醫學版)
호남사범대학학보(의학판)
JOURNAL OF HUNAN NORMAL UNIVERSITY(MEDICAL SCIENCE)
2013年
4期
1-4,10
,共5页
王炜%毕家香%周利民%李蓉%唐蓉娥%叶湘漓%李启星%雷立芳
王煒%畢傢香%週利民%李蓉%唐蓉娥%葉湘巑%李啟星%雷立芳
왕위%필가향%주이민%리용%당용아%협상리%리계성%뢰립방
脑卒中%卒中数据库%危险因素
腦卒中%卒中數據庫%危險因素
뇌졸중%졸중수거고%위험인소
stroke%stroke data bank%Risk factors
目的:初步建设具有湖南湘潭地区特点的脑卒中数据库,研究本地区不同年龄组卒中患者的人口学及危险因素构成等指标,为脑卒中的预防及治疗提供依据。方法:参照成都卒中登记项目以及南京卒中注册登记项目,采用前瞻性多中心调查方式,收集2009年1月~2012年5月间在湘潭地区多中心脑卒中登记项目中注册的2082例卒中患者的人口学、病因学、临床特点和危险因素等资料,登记编码,建成数据库。结果:纳入数据库的2082例患者中,包括男性1230例(占59.08%),女性852例(占40.92%);其中,诊断脑梗死1431例(占68.73%),短暂性脑缺血发作(TIA)141例(占6.77%),脑出血417例(占20.03%),蛛网膜下腔出血(SAH)93例(占4.47%);平均年龄为65.71±10.06岁;青年组卒中(<45岁)192例(占9.22%),危险因素由高到低依次为高血压病、吸烟、饮酒、高脂血症、糖尿病、卒中家族史、心脏病、药物滥用、脑卒中病史;中老年组卒中(≥45岁)1890例(占90.78%),危险因素由高到低依次为高血压病、心脏病、糖尿病、吸烟、饮酒、高脂血症、卒中家族史、脑卒中病史、药物滥用,青年卒中与中老年卒中的病因及危险因素等均存在差异性。结论:湘潭地区不同年龄组脑卒中患者的危险因素构成存在差异,故应根据年龄差别有针对性的开展脑卒中的一、二级预防;以医院为基础建立的多中心卒中数据库切实反映了湘潭地区脑卒中的现状及特点,为脑卒中的防治提供了可靠的依据。
目的:初步建設具有湖南湘潭地區特點的腦卒中數據庫,研究本地區不同年齡組卒中患者的人口學及危險因素構成等指標,為腦卒中的預防及治療提供依據。方法:參照成都卒中登記項目以及南京卒中註冊登記項目,採用前瞻性多中心調查方式,收集2009年1月~2012年5月間在湘潭地區多中心腦卒中登記項目中註冊的2082例卒中患者的人口學、病因學、臨床特點和危險因素等資料,登記編碼,建成數據庫。結果:納入數據庫的2082例患者中,包括男性1230例(佔59.08%),女性852例(佔40.92%);其中,診斷腦梗死1431例(佔68.73%),短暫性腦缺血髮作(TIA)141例(佔6.77%),腦齣血417例(佔20.03%),蛛網膜下腔齣血(SAH)93例(佔4.47%);平均年齡為65.71±10.06歲;青年組卒中(<45歲)192例(佔9.22%),危險因素由高到低依次為高血壓病、吸煙、飲酒、高脂血癥、糖尿病、卒中傢族史、心髒病、藥物濫用、腦卒中病史;中老年組卒中(≥45歲)1890例(佔90.78%),危險因素由高到低依次為高血壓病、心髒病、糖尿病、吸煙、飲酒、高脂血癥、卒中傢族史、腦卒中病史、藥物濫用,青年卒中與中老年卒中的病因及危險因素等均存在差異性。結論:湘潭地區不同年齡組腦卒中患者的危險因素構成存在差異,故應根據年齡差彆有針對性的開展腦卒中的一、二級預防;以醫院為基礎建立的多中心卒中數據庫切實反映瞭湘潭地區腦卒中的現狀及特點,為腦卒中的防治提供瞭可靠的依據。
목적:초보건설구유호남상담지구특점적뇌졸중수거고,연구본지구불동년령조졸중환자적인구학급위험인소구성등지표,위뇌졸중적예방급치료제공의거。방법:삼조성도졸중등기항목이급남경졸중주책등기항목,채용전첨성다중심조사방식,수집2009년1월~2012년5월간재상담지구다중심뇌졸중등기항목중주책적2082례졸중환자적인구학、병인학、림상특점화위험인소등자료,등기편마,건성수거고。결과:납입수거고적2082례환자중,포괄남성1230례(점59.08%),녀성852례(점40.92%);기중,진단뇌경사1431례(점68.73%),단잠성뇌결혈발작(TIA)141례(점6.77%),뇌출혈417례(점20.03%),주망막하강출혈(SAH)93례(점4.47%);평균년령위65.71±10.06세;청년조졸중(<45세)192례(점9.22%),위험인소유고도저의차위고혈압병、흡연、음주、고지혈증、당뇨병、졸중가족사、심장병、약물람용、뇌졸중병사;중노년조졸중(≥45세)1890례(점90.78%),위험인소유고도저의차위고혈압병、심장병、당뇨병、흡연、음주、고지혈증、졸중가족사、뇌졸중병사、약물람용,청년졸중여중노년졸중적병인급위험인소등균존재차이성。결론:상담지구불동년령조뇌졸중환자적위험인소구성존재차이,고응근거년령차별유침대성적개전뇌졸중적일、이급예방;이의원위기출건립적다중심졸중수거고절실반영료상담지구뇌졸중적현상급특점,위뇌졸중적방치제공료가고적의거。
Objective To set up a preliminary construction of Stroke data bank of Xiangtan region and to study the information of demography and risk factors between different age groups of stroke cases in this region which can provide evidence for the prevention and treatment of stroke. Methods According to the way of Chengdu Stroke Registry Program and Nanjing Stroke Registry Program, we used 2082 stroke cases prospectively, which had been registered in a multi-hospital system of stroke cases in Xiangtan region between January 2009 to May 2012. The demographic, etiologic, clinical parameters and risk factors of the patients were recorded in a comput-erized stroke date bank. Results A total of 2082 cases, including 1230 males (59.08%) and 852 females (40.92%), were computerized. Among them, 1431 (68.73%) were diagnosed cerebral infarction, 141 (6.77%) were diagnosed transient ischemic attack (TIA), 417 (20.03%) were diagnosed intracerebral hemorrhage, 93 (4.47%) were diag-nosed subarachnoid hemorrhage (SAH). The average age is 65.71 ± 10.06 years. The number of young stroke pa-tients (<45 years) is 192 (9.22%) and the risk factors for stroke ranged from high to low are hypertension, smoking,drinking, family history of stroke, hyperlipidemia, diabetes, stroke, heart disease, drug abuse and prior stroke his-tory. The number of elderly stroke patients (≧45 years) is 1890 (90.78%) and the risk factors for stroke ranged from high to low are hypertension, heart disease, diabetes, smoking, drinking, family history of stroke, hyperlipi-demia, prior stroke history and drug abuse. Conclusion As there are differences in the risk factors of stroke cases between different age groups, it is suitable to perform a targeted primary or secondary prevention according to the age of stroke cases. The multi-hospital system of stroke cases in Xiangtan truly shows the present situation and features in the region, and provide reliable evidence for preventing and treating stroke.